This study aimed to evaluate the effectiveness and safety of plasmapheresis in individuals with acute MOGAD attacks. Learn more: https://t.co/AM8PupkPxN
When standard steroid treatment isn't enough, another therapy may help people recover from rare inflammatory attacks.
A recent review found plasmapheresis was linked to better recovery in people with MOGAD.
Read more: https://t.co/dvMl9dqaLh @MVilardo@GreenJournal
That’s a wrap on #AANAM from Cleveland Clinic Neurology!
From our incoming PGY-1s, current residents, fellows, faculty, and all the way to our Chair, CCF was well represented across the meeting.
@ClevelandClinic@AANmember
Still feels like a dream… I will be a Neurologist at the place that owns my heart @CLENeurons! 🥹
“Do your best and God will do the rest” has never felt so true. HUGE thanks to my family, friends, and mentors who believed in me and pushed me beyond what I ever imagined. 💚🤍💙
🧠 Nearly half of people may experience #headaches after a hemorrhagic #stroke, many lasting months or years. A recent review highlights the need for better recognition & care.
🔗https://t.co/eW0OOt21TE
@bradleyongmd@shervinbd@MVilardo et al
Hey #MedTwitter!
I’m Marina, MD from 🇧🇷 & Neuroimmuno Research Fellow at @MGHNeurology. Passionate about all that is Neuro 🧠
Outside medicine, I enjoy time with family and friends, the outdoors, and good movies🏔️🍿
Thrilled for the #Neurology#Match2026! Best wishes to all✨